Tadacip: Uses, Benefits And Active Ingredients

Tadacip is a popular medication used to treat erectile dysfunction (ED) in men. It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, which work by increasing blood flow to the penis, allowing men to achieve and maintain an erection. Tadacip is manufactured by Cipla, a leading Indian pharmaceutical company, and has been approved by the U.S. Food and Drug Administration (FDA).

The discovery of Tadacip began in the late 1980s when researchers began studying the effects of PDE5 inhibitors on the body. The drug was originally developed by GlaxoSmithKline (GSK) and was approved by the FDA in 1998. Since then, Tadacip has become one of the most popular ED treatments available on the market today.

Tadacip contains the active ingredient tadalafil, which is a PDE5 inhibitor. Tadalafil works by blocking the action of the enzyme PDE5, which is responsible for the breakdown of cyclic guanosine monophosphate (cGMP) in the penis. By blocking the action of PDE5, tadalafil increases the levels of cGMP, allowing for increased blood flow to the penis and improved erectile function.

Tadacip is available in tablets of 10 mg, 20 mg, and 40 mg. It should be taken 30 minutes to 1 hour before sexual activity, and the effects can last up to 36 hours. Common side effects of Tadacip include headaches, flushing, indigestion, muscle pain, and back pain.

Tadacip is also known by its generic name, tadalafil, and other synonyms such as Cialis, Adcirca, and Tadarise. It is important to note that Tadacip is not a cure for ED and should only be taken as prescribed by your doctor. It is also important to remember that Tadacip should not be taken more than once per day.

Tadacip is an effective and safe treatment for ED that has been proven to improve the quality of life of those who take it. It is important to speak to your doctor before taking Tadacip to ensure that it is the right treatment for you.

Leave a Comment

Your email address will not be published. Required fields are marked *